| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $30.5M | +57.9% |
| SG&A Expense | $17.8M | +26.4% |
| Operating Income | -$48.3M | -44.6% |
| Interest Expense | $2.1M | +201.4% |
| Pre-tax Income | -$38.2M | +30.8% |
| Income Tax | $0 | — |
| Net Income | -$38.2M | +30.8% |
| EPS (Basic) | -$0.72 | +58.6% |
| EPS (Diluted) | -$0.72 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $119.7M | +16.6% |
| Current Assets | $121.4M | +16.9% |
| Total Assets | $125.2M | +17.2% |
| Current Liabilities | $9.0M | -76.0% |
| Total Liabilities | $73.3M | +80.7% |
| Stockholders' Equity | $51.9M | -21.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$38.3M | -41.8% |
| Capital Expenditures | $587K | +3568.8% |
| Investing Cash Flow | -$560K | -3400.0% |
| Financing Cash Flow | $56.1M | -40.5% |
| Free Cash Flow | -$38.9M | -43.9% |
| +58.6% |